Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.87 - $1.71 $3,523 - $6,925
-4,050 Reduced 1.92%
206,555 $353,000
Q2 2023

Aug 14, 2023

SELL
$0.83 - $1.18 $629,110 - $894,398
-757,965 Reduced 78.26%
210,605 $242,000
Q1 2023

May 15, 2023

BUY
$0.8 - $4.98 $66,221 - $412,229
82,777 Added 9.34%
968,570 $784,000
Q4 2022

Feb 14, 2023

BUY
$1.88 - $36.45 $19,629 - $380,574
10,441 Added 1.19%
885,793 $2.11 Million
Q3 2022

Nov 15, 2022

SELL
$2.5 - $37.95 $10.6 Million - $160 Million
-4,223,317 Reduced 82.83%
875,352 $1.99 Million
Q2 2022

Aug 15, 2022

BUY
$1.75 - $11.34 $6.48 Million - $42 Million
3,705,283 Added 265.92%
5,098,669 $12.5 Million
Q1 2022

May 16, 2022

BUY
$10.21 - $20.29 $1.28 Million - $2.55 Million
125,571 Added 9.9%
1,393,386 $14.2 Million
Q4 2021

Feb 14, 2022

BUY
$16.76 - $22.99 $12.7 Million - $17.5 Million
759,911 Added 149.62%
1,267,815 $25 Million
Q3 2021

Nov 15, 2021

BUY
$13.15 - $22.56 $2.06 Million - $3.53 Million
156,591 Added 44.57%
507,904 $9.39 Million
Q2 2021

Aug 16, 2021

SELL
$18.28 - $33.05 $6.93 Million - $12.5 Million
-378,844 Reduced 51.89%
351,313 $6.42 Million
Q1 2021

May 17, 2021

BUY
$29.34 - $60.2 $16.4 Million - $33.7 Million
559,388 Added 327.57%
730,157 $23.9 Million
Q4 2020

Feb 16, 2021

BUY
$27.25 - $55.82 $4.65 Million - $9.53 Million
170,769 New
170,769 $9.4 Million

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0

About Praxis Precision Medicines, Inc.


  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.